-

‘I Am the Only Person Stupid Enough to Speak After Michelle Obama’
So said former President Barack Obama after his wife electrified the Democratic National Convention. The delegates loved him, but they really loved her.
-

How Kamala Harris Is Trying to Claim the Mantle of Change
Ms. Harris is working to embody a powerful political force. But Donald J. Trump doesn’t want to let the incumbent party sell itself as anything but the status quo.
-

How to Find the Best Deals on Travel Packages
Traveling is a dream for many people – the chance to explore new cultures, try new foods, and create unforgettable memories. However, the cost of traveling can often be a barrier for those looking to fulfill their wanderlust. But fear not, fellow travelers, as there are ways to find the best deals on travel packages…
-

Right To Know – August 2024, Vol. 20
Cyber, Privacy, and Technology Report – Welcome to your monthly rundown of all things cyber, privacy, and technology, where we highlight all the happenings you may have missed….By: Clark Hill PLC
-

Life Sciences Industry Update: 2024 Mid-Year Report
ARTIFICIAL INTELLIGENCE IN LIFE SCIENCES – Life sciences companies are forming AI-driven strategic collaborations with tech giants, creating synergy that promises to revolutionize the industry. Companies like NVIDIA, Microsoft, Google, and AWS are at the forefront of these partnerships, leveraging their advanced AI capabilities to enhance various aspects of life sciences operations….By: Ballard Spahr LLP
-

NIST Releases Three Post-Quantum Cryptography Standards
As discussed in a previous post, in 2022, the Quantum Computing Cybersecurity Preparedness Act ordered an examination of federal administrative agencies’ data cryptography to prepare for a future where quantum computing is capable of decrypting that data. Among the law’s provisions was a directive triggered by the completion of the National Institute of Standards and…
-

Pharmacyclics LLC v. Alvogen Pine Brook LLC – Imbruvica® (Ibrutinib)
Case Name: Pharmacyclics LLC v. Alvogen Pine Brook LLC, Civ. No. 19-434-CFC, 2024 WL 1885677 (D. Del. Apr. 30, 2024) (Connolly, J.) – Drug Product and Patent(s)-in-Suit: Imbruvica® (ibrutinib); U.S. Patents Nos. 8,008,309 (“the ’309 patent”), 8,754,090 (“the ’090 patent”), 9,655,857 (“the ’857 patent”), and 9,725,455 (“the ’455 patent”)….By: Robins Kaplan LLP
-

Seattle Tech Week Takeaways: How Software Investors Fund the Right Fit
When an investor is thinking about betting on an up-and-coming software innovator, what do they look for? We asked, and they answered….By: Fenwick & West LLP
-

Toyota Confirms Recent Data Breach; Investigation Ongoing
On August 19, 2024, Toyota confirmed reports that the company experienced a data breach affecting personal information belonging to an unknown number of employees and customers. While Toyota has acknowledged the breach, the company’s investigation is still ongoing. However, upon completing its investigation, Toyota will likely send out data breach notification letters to anyone whose…
-

Revenue Cycle Management Company, Nobility LLC, Provides Notice of Data Breach
On August 16, 2024, revenue cycle management company Nobility LLC (“Nobility RCM”) filed a notice of data breach with the Attorney General of Texas after discovering that an unauthorized party was able to access confidential information that had been entrusted to the company. In this notice, Nobility RCM explains that the incident resulted in an…